By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights ...
Researchers are now exploring strategies to silence cccDNA, aiming for a functional cure and offering hope to millions of patients worldwide. Hepatitis B virus infection remains one of the leading ...
Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...
Researchers are now exploring strategies to silence cccDNA, aiming for a functional cure and offering hope to millions of patients worldwide. Hepatitis B virus infection remains one of the leading ...
People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Analysts at William Blair have suggested that the market for an HBV cure could be around the same size as for hepatitis C virus, which peaked at around $10 billion a year but was a short-lived ...
Analysts at William Blair have suggested that the market for an HBV cure could be around the same size as for hepatitis C virus, which peaked at around $10 billion a year, but was a short-lived ...